tiprankstipranks
Revolution Medicines, Inc. (RVMD)
NASDAQ:RVMD
US Market
RVMD
Revolution Medicines
RESEARCH TOOLSreports
Want to see RVMD full AI Analyst Report?

Revolution Medicines (RVMD) Income Statement

762 Followers

Revolution Medicines Income Statement

Last quarter (Q1 2026), Revolution Medicines's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Revolution Medicines's net income was $-453.82M. See Revolution Medicines’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 11.58M$ 35.38M$ 29.39M
Gross Profit
$ -16.56M$ 0.00$ 11.58M$ 35.38M$ 29.39M
Operating Expenses
$ 1.17B$ 689.52M$ 498.76M$ 293.66M$ 217.40M
Depreciation and Amortization
$ 16.56M$ 11.82M$ 9.31M$ 9.66M$ 7.33M
EBITDA
$ -1.09B$ -677.70M$ -477.88M$ -248.62M$ -179.75M
Operating Income
$ -1.18B$ -689.52M$ -487.19M$ -258.28M$ -188.01M
Other Income/Expenses
$ 51.07M$ 88.68M$ 47.29M$ 9.15M$ 917.00K
Pretax Income
$ -1.13B$ -600.85M$ -439.89M$ -249.13M$ -187.09M
Net Income
$ -1.13B$ -600.09M$ -436.37M$ -248.71M$ -187.09M
Per Share Metrics
Basic EPS
$ -5.95$ -3.58$ -3.86$ -3.08$ -2.47
Diluted EPS
$ -5.95$ -3.58$ -3.86$ -3.08$ -2.47
Weighted Average Shares Outstanding
 190.13M 167.74M 113.15M 80.63M 72.81M
Weighted Average Shares Outstanding (Diluted)
 190.13M 167.74M 113.15M 80.63M 72.81M
Currency in USD

Revolution Medicines Earnings and Revenue History